B

Biogen

Develops therapies for neurological disorders

CMC Commercial Asset Development Lead

Bioprocess & BiomanufacturingConfirmed live in the last 24 hours
Full-time

About the Job

Requirements

  • A BS or equivalent in sciences or engineering is required; an advanced degree (MS, PhD, or MBA) in a relevant biopharmaceutical discipline is preferred.
  • At least 12 years of experience, with a focus on matrix management.
  • A track record of effective matrix leadership in program teams across the full product life cycle, such as CMC PO&T line-function sub-teams or other cross-functional teams in a matrix environment, ideally across an organization.
  • Alliance management experience, preferably global, and understanding of business contracts and management.
  • Experience with CMC, supply chain, or life-cycle-management development from IND to NDA/BLA, including a solid understanding of global registration processes, and technical expertise in a relevant biopharmaceutical development discipline.
  • Experience in the healthcare, biotech, or pharmaceutical industry and demonstrated understanding of cross-functional interdependencies, including R&D, commercial, technical development, and regulatory.
  • Strategic, political, organizational, and relationship-development skills.
  • Ability to lead, motivate, and influence strategic direction without authority, and to leverage and develop diverse perspectives and ideas from matrix teams and others.
  • Communication, negotiation, problem-solving, and decision-making abilities.
  • Ability to identify critical program risks and develop strategic or tactical mitigation plans addressing risk, cost, and reputation.

Responsibilities

  • Oversee development and implementation of a five-year PO&T Asset Strategy and maintain an 18-month rolling Tactical Plan, aligning them with company objectives and enabling the PO&T Leadership team to make informed asset decisions.
  • Lead the cross-functional PO&T Asset Team, comprising representatives from each PO&T Line Function, to ensure cohesive execution of the PO&T Asset Strategy and Tactical Plan.
  • Represent PO&T on R&D Program teams and PDC teams, fostering collaboration and communication among R&D, Commercial, and PO&T to support assets.
  • Address and manage conflicts related to the Asset Strategy in consultation with the PO&T Governance Committee, balancing PO&T Line Functions' priorities with the Asset Strategy.
  • Track and assess asset-related impacts on financial metrics such as COGS, E&O, and OPEX, and work with PO&T Line Functions to develop improvement strategies.
  • Develop business cases for significant asset initiatives and secure endorsement and approval from the PO&T Governance Committee.
  • Lead teams representing PO&T disciplines and maintain partnerships with relevant program R&D and product commercial leaders.
  • Lead and facilitate aspects of the PO&T vision, including influencing and collaborating through oversight of collaborations and interfaces with BD and External Innovation.
  • Drive best practices for resource management, forecasting decision gates, and associated knowledge-management initiatives.

Desired Qualifications

  • An advanced degree (MS, PhD, or MBA) in a relevant biopharmaceutical discipline.
  • Global alliance management experience.
  • Matrix leadership experience across an organization.

About the Company

Biogen

Develops therapies for neurological disorders

Biogen is a global biotechnology company focused on neuroscience. It discovers, develops, and delivers therapies for neurological disorders, such as multiple sclerosis and other neurodegenerative diseases. Its product process starts with research and development to identify potential drugs, followed by clinical testing and regulatory approval, ultimately leading to commercialization and patient treatment. Biogen differentiates itself through a long history (founded in 1978), a deep specialization in neuroscience, and an integrated pipeline that moves ideas from discovery to approved medicines, aiming to create value for shareholders while helping communities. The company’s goal is to advance therapies for neurological diseases to improve patients’ lives and generate sustainable value for stakeholders.

Company size
5,001-10,000
Company stage
IPO
Headquarters
Cambridge, MA
Founded
1978

Recently Posted Jobs

Explore more opportunities at Biogen

See more jobs